Intra-Abdominal Pressure Measurement Devices Market

Intra-Abdominal Pressure Measurement Devices Market Size (2023 to 2028)

As per our report, the size of the Global Intra-Abdominal Pressure Measurement Devices Market is estimated to account for USD 643 million in 2023. This market is predicted to grow at a CAGR of 16.5% and will account for USD 1738 million by 2028.

Intra-abdominal pressure measurement devices are the medical devices used to measure intra-abdominal pressure (IAP) to recognize individuals who are at risk of abdominal compartment syndrome (ACS) and intra-abdominal hypertension (IAH). The IAH and ACS can cause illness and death because of cardiac output and decreased venous return. The IAH is generally affected by too much intra-abdominal volume within the abdominal cavity. IAH refers to a pressure greater than 12mmHg, and the normal IAP for positively ill patients in adults ranges between 5-7mmHg. Intra-abdominal pressure monitoring is essential in diagnosing, preventing, and managing IAH and ACS. For instance, according to an article published in the Critical Care Medicine Journal in 2019, 38-45% of patients develop intra-abdominal hypertension those treated in ICU settings. According to the Health Department of the Australian Government, the frequent occurrence of IAH may range from 1-50% of ICU patients. IAP can be measured using direct and indirect procedures. Direct measurement can be done using a needle and catheter in the peritoneal space and is the most accurate method. Abdominal compartment syndrome (ACS) highlights the organ dysfunction caused by intra-abdominal hypertension (IAH), and it may be underrated as it mainly affects patients who are already ill. Therefore, their organ dysfunction may be inaccurately attributed to the advancement of the illness.

MARKET DRIVERS:

The aged population is likelier to diseases related to the intra-abdominal, and a high incidence of this cause has been noticed since the last decade, which is estimated to fuel the market growth of Intra-Abdominal Pressure Measurement Devices. According to the Health Department of the Australian Government, the occurrence of IAH ranges from 1-50% in intensive care patients.

YOY rise in the incidence of chronic and infectious diseases worldwide further propels the market growth.

The increasing number of intra-abdominal hypertension cases and the increase of ICS and IHS also surge the market growth of IPMD. Furthermore, technological advancements in surgical techniques, dominance in the treatment protocol, and the importance of the prophylactic abdominal decompression process for trauma treatment swell the IPMD market growth over the analysis period. Moreover, the launch of new products, approvals, and accessibility of those devices and therapeutics is also accelerating the IPMD market.

MARKET RESTRAINTS:

The costs associated with inserting equipment like catheters and transducers into the abdominal cavity or the stomach areare expensive, which is one of the primary factors restraining the market growth of Intra-Abdominal Pressure Measurement Devices. In addition, strict guidelines, complex surgeries, and side effects associated with post-surgeries may hinder the IPMD market growth over the analysis period. The shortage of expert professionals and the lack of insufficient infrastructure and equipment needed for the surgery process is further limiting the growth of the market.

Impact Of COVID-19 on the intra-abdominal pressure measurement devices market:

The sudden outburst of the COVID-19 pandemic has spread over all the countries worldwide and was declared a public health emergency issued by the World Health Organization. Around 25.6 million infected people across the world. During the COVID-19 crisis, there is a significant demand for growth in intra-abdominal pressure measurement devices. These pressure measurement devices monitor vital signs in patients with mild symptoms resulting in death. Over the crisis, various healthcare regulatory authorities issued guidelines for patients needing critical care. For example, on March 20, 2020, National Institute for Clinical Excellence (NICE) published policies to ensure patients' safety who require acute care during the pandemic and protect the staff from virus infection. Moreover, advanced technologies with wireless devices for treating patients with the disorder.

REPORT COVERAGE:

This market research report on the global intra-abdominal pressure measurement devices market has been segmented and sub-segmented based on the Product, Procedure, Application, End-User, and Region.

Intra-Abdominal Pressure Measurement Devices Market - By Product:

• Disposables
• Equipment

The equipment segment is expected to dominate the market during the forecast period because using instruments is an indirect treatment method, does not imply any direct side effects to the body, and is also a budget-friendly process. Additionally, types of equipment assist the healthcare professionals like surgeons in getting a better view of the patient's situation during the surgical procedure, further promoting the segment's revenue.  

The disposables segment is also expected to have high revenue due to its demand in situations when an indirect measuring method does not meet the requirements to assess the abdominal situation. For example, direct measuring items like an intraperitoneal catheter, tubing pumps, and needles help healthcare professionals correctly measure and prevent blood overflow and bladder trauma. 

Intra-Abdominal Pressure Measurement Devices Market - By Procedure:

• Muscle
• Abdomen

The abdomen segment is expected to dominate the market during the forecast period due to the rising cases of intraabdominal problems and the use of devices for intraabdominal hypertension. In addition, the abdomen is also more focussed on as extra pressure on the abdomen can cause damage to the internal organs causing significant damage. 

The muscle segment is also expected to show fast growth during the forecast period due to the after-effects of surgeries and increasing cases of muscle burns, trauma, and pains. Sometimes, surgeries can also result in dysfunctional muscles. Therefore, the segment is expected to have revenue due to the several muscle conditions. 

Intra-Abdominal Pressure Measurement Devices Market - By Application:

• Intra-Compartment Pressure
• Intra-Abdominal Hypertension

The Intra-abdominal Hypertension segment is expected to dominate the market during the forecast period due to several conditions leading to these conditions. The condition is prevalent due to several postoperative complications like postoperative hemorrhage leading to this condition along with other respiratory, thoracic, and pancreatic problems leading to this condition. 

However, the Intra-Compartment Pressure segment is expected to have the second highest revenue for the market due to the prevalence of the condition being almost 30-40%. 

Intra-Abdominal Pressure Measurement Devices Market - By End-user:

• Hospitals
• Trauma centers
• Ambulatory surgical centers (ASCs)
• Clinics

The hospital segment is expected to dominate the market during the forecast period due to the rising influx of patients in hospital settings and the credibility of hospital care for people. In addition, hospitals are large infrastructures with good facilities available and have widespread reach for services and well-educated professionals. 

However, the clinic's segment is right behind the hospitals due to the rising number of local healthcare centers and the rising research and development activities in several clinical spaces. 

Intra-Abdominal Pressure Measurement Devices Market - By Region:

• North America
  • The United States
  • Canada
  • Rest of North America
• Europe
  • UK
  • Germany
  • Italy
  • Spain
  • France
  • Rest of E.U.
• Asia-Pacific
  • India
  • China
  • Japan
  • Australia
  • New Zealand
  • South Korea
  • Rest of APAC
• Latin America
  • Mexico
  • Brazil
  • Argentina
  • Chile
  • Rest of Latin America
• Middle East
• Africa

Regionally, North America is the market leader capturing more than half of the market share. It is predicted to thrive in the forecast mentioned above period. Europe is the second-largest market. It will experience sluggish growth until 2028. The Asia Pacific is set on a high growth trajectory.

Latin America is also likely to experience slow growth until the end of the forecast period. The Middle East and Africa are the least attractive market, with the lowest market penetration and growth rate. It has an attractive index of 0.1.

KEY MARKET PLAYERS:

Companies playing a significant role in the global intra-abdominal pressure measurement devices market profiled in this report are C. R. Bard, Inc., ConvaTec Group PLC, Holtech Medical, Centurion Medical Products, Biometrix Ltd. (Degania Silicone, Ltd.), Stryker Corporation, Spiegelberg GmbH, Nutrimedics S.A. (Greece), Potrero Medical Inc. (U.S.) and Gaeltec (U.K.).

RECENT MARKET DEVELOPMENTS:                                                                 

• In September 2022, Potrero Medical revealed that its AKI Predict machine learning algorithm had been given FDA breakthrough device classification.
• In July 2022, La Jolla Pharmaceutical Company (Nasdaq: LJPC), which is committed to the commercialization of cutting-edge therapies that improve outcomes in patients with life-threatening diseases, and Innoviva, Inc., a diversified holding company with a portfolio of royalties and a growing portfolio of cutting-edge healthcare assets, today announced that they have entered into a definitive merger agreement under which Innoviva will acquire La Jolla. The Food and Drug Administration (FDA) approved GIAPREZA® (angiotensin II), the company's flagship medicine, in December 2017 to raise blood pressure in people experiencing septic or another distributive shock. In addition, the FDA authorized XERAVA® (eravacycline), the second asset of La Jolla, in August 2018 for managing complex intra-abdominal infections (Cialis) in adults.
• Based in Hayward, California, in cardiac post-surgical intensive care patients, Potrero developed its method for the advanced prediction of acute kidney injury (AKI) related to intra-abdominal hypertension (IAH).
• In September 2022, The Accuryn monitoring system from Potrero Medical (Hayward, CA, USA) automates continuous monitoring of U.O., IAP, and core body temperature to identify clinical trends of AKI and enhance productivity. Currently, a monitoring device converts the conventional Foley catheter into a cutting-edge sensor for precise, immediate detection of urine output (U.O.), intra-abdominal pressure (IAP), and core body temperature to assist care.
• In January 2021, with Elcam Medical's help and a $1.5 million investment, Serenno Medical can mass-produce a urine monitoring gadget to identify kidney damage in hospitalized patients. An output and intra-abdominal pressure digital monitoring equipment for identifying acute kidney injury has been created by Sereno, based in Yokne'am Illit, Israel (AKI). The business claimed its Sentinel gadget offered a simple, cost-effective solution for real-time, accurate, continuous urine volume and flow rate measurement.